Diabetes in Control publishes complete list of drugs that affect blood glucose

Any clinician knows that there's a massive amount of new diabetes research and clinical information released daily, which makes keeping pace with best practices almost a full-time job. But Diabetes in Control (http://www.diabetesincontrol.com), an e-newsletter dedicated to helping clinicians stay current and achieve the best possible health outcomes, provides its readers with concise, timely, crucial information to improve outcomes and patient quality of life. As an excellent example, Diabetes in Control just posted the most current, comprehensive list of "Drugs That Affect Blood Glucose Levels," available as a download (http://www.diabetesincontrol.com/tools/tools-for-your-practice/9625-drugs-that-can-affect-blood-glucose-levels) for no cost. The list is designed to serve as a quick, handy reference for practitioners who need to assess the potential dangers of such drugs for their patients.

"Diabetes is a dangerous disease to treat," says Dave Joffe, R.Ph, chief editor of Diabetes in Control. "Over 10 percent of adverse medication events are attributed to medications that can actually harm diabetics. In response, our research team of doctoral candidate pharmacists has compiled this comprehensive list of drugs that affect blood glucose because it's imperative to keep these in mind when evaluating or prescribing these medications to diabetes patients."

The list includes 300+ drugs  - and associated brand names - that could trigger either hyperglycemia or hypoglycemia specifically, as well as those that can cause either condition to manifest unexpectedly. The list, which also names drugs that mask hypoglycemia, is just one of many tools and resources provided by Diabetes in Control, which sets goals that address error prevention, safety know-how and advocacy, awareness of lessons learned, voluntary error reporting, and patient compliance. The online publication combines two notable diabetes clinical newsletters that publish articles and writings from leading medical practitioners and industry experts; news that focuses on innovative methods to improving outcomes and standards of care; just-released information on drugs, devices, treatments and services; and free CE and CME opportunities.

"Our publication is becoming increasingly important considering the decline in the availability of diabetes educators, as the epidemic grows," says Andrew Young, president of Diabetes in Control. "Also, diabetes practitioners are so pressed with their hands-on work, they have little time to devote to ongoing education. Diabetes in Control is easily accessible, free, reliable and ever-current, providing a welcome solution through Internet-supported diabetes education."